Next, we overexpressed ANXA1 in RRM2-silenced PCa cells and observed that the decrease in docetaxel resistance resulting from RRM2 suppression was largely reversed by ANXA1 overexpression (Fig. 7A). The gene discussed is ANXA1; the disease is posterior cortical atrophy.